Vasundhara Rasayans Past Earnings Performance
Past criteria checks 5/6
Vasundhara Rasayans has been growing earnings at an average annual rate of 23.6%, while the Pharmaceuticals industry saw earnings growing at 13.3% annually. Revenues have been growing at an average rate of 14.7% per year. Vasundhara Rasayans's return on equity is 15.8%, and it has net margins of 15.9%.
Key information
23.6%
Earnings growth rate
23.6%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 14.7% |
| Return on equity | 15.8% |
| Net Margin | 15.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Vasundhara Rasayans makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 368 | 58 | 45 | 0 |
| 30 Jun 24 | 363 | 58 | 35 | 0 |
| 31 Mar 24 | 370 | 59 | 42 | 0 |
| 31 Dec 23 | 358 | 42 | 40 | 0 |
| 30 Sep 23 | 357 | 45 | 38 | 0 |
| 30 Jun 23 | 364 | 60 | 37 | 0 |
| 31 Mar 23 | 379 | 56 | 36 | 0 |
| 31 Dec 22 | 370 | 66 | 14 | 0 |
| 30 Sep 22 | 354 | 53 | 22 | 0 |
| 30 Jun 22 | 295 | 13 | 26 | 0 |
| 31 Mar 22 | 268 | 22 | 30 | 0 |
| 31 Dec 21 | 238 | 11 | 41 | 0 |
| 30 Sep 21 | 232 | 17 | 49 | 0 |
| 30 Jun 21 | 258 | 38 | 40 | 0 |
| 31 Mar 21 | 227 | 29 | 41 | 0 |
| 31 Dec 20 | 217 | 34 | 44 | 0 |
| 30 Sep 20 | 216 | 35 | 35 | 0 |
| 30 Jun 20 | 203 | 29 | 35 | 0 |
| 31 Mar 20 | 213 | 30 | 44 | 0 |
| 31 Dec 19 | 214 | 14 | 42 | 0 |
| 30 Sep 19 | 200 | 7 | 42 | 0 |
| 30 Jun 19 | 197 | 10 | 34 | 0 |
| 31 Mar 19 | 198 | 15 | 41 | 0 |
| 31 Dec 18 | 191 | 13 | 29 | 0 |
| 30 Sep 18 | 231 | 19 | 35 | 0 |
| 30 Jun 18 | 174 | 73 | 29 | 0 |
| 31 Mar 18 | 166 | 65 | 28 | 0 |
| 31 Mar 17 | 154 | 5 | 33 | 0 |
| 31 Mar 16 | 153 | 2 | 22 | 0 |
| 31 Mar 15 | 185 | 6 | 24 | 0 |
| 31 Dec 14 | 189 | 6 | 23 | 0 |
| 30 Sep 14 | 191 | 8 | 23 | 0 |
| 30 Jun 14 | 202 | 19 | 22 | 0 |
| 31 Mar 14 | 209 | 14 | 36 | 0 |
| 31 Dec 13 | 209 | 16 | 23 | 0 |
Quality Earnings: 538634 has high quality earnings.
Growing Profit Margin: 538634's current net profit margins (15.9%) are higher than last year (12.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 538634's earnings have grown significantly by 23.6% per year over the past 5 years.
Accelerating Growth: 538634's earnings growth over the past year (29.8%) exceeds its 5-year average (23.6% per year).
Earnings vs Industry: 538634 earnings growth over the past year (29.8%) exceeded the Pharmaceuticals industry 20.5%.
Return on Equity
High ROE: 538634's Return on Equity (15.8%) is considered low.